Hiroko Tonai-Kachi

5-Nitro-2-(3-Phenylpropylamino)benzoic Acid Is a GPR35 Agonist

K. Shinjo, Yasuhito Taniguchi, Hiroko Tonai-Kachi, 2008, Pharmacology.

Zaprinast, a well‐known cyclic guanosine monophosphate‐specific phosphodiesterase inhibitor, is an agonist for GPR35

K. Shinjo, Yasuhito Taniguchi, Hiroko Tonai-Kachi, 2006, FEBS letters.

Effect of prostanoid EP4 receptor antagonist, CJ-042,794, in rat models of pain and inflammation.

Kazunari Nakao, Takako Okumura, Hiroko Tonai-Kachi, 2008, European journal of pharmacology.

CJ-21,164, a new D-glucose-6-phosphate phosphohydrolase inhibitor produced by a fungus Chloridium sp.

N. Yoshikawa, H. Nishida, Y. Kojima, 2002, The Journal of antibiotics.

Thielavins as glucose-6-phosphatase (G6Pase) inhibitors: producing strain, fermentation, isolation, structural elucidation and biological activities.

N. Kojima, N. Yoshikawa, H. Nishida, 2002, The Journal of antibiotics.

GPR35 is a functional receptor in rat dorsal root ganglion neurons.

Hiroyuki Ohshiro, Katsuomi Ichikawa, Hiroko Tonai-Kachi, 2008, Biochemical and biophysical research communications.

In vitro pharmacological characterization of CJ-042794, a novel, potent, and selective prostaglandin EP(4) receptor antagonist.

Kazunari Nakao, Yasuhito Taniguchi, Hiroko Tonai-Kachi, 2008, Life sciences.

N-(2-Hydroxyethyl)-N,2-dimethyl-8-{[(4R)-5-methyl-3,4-dihydro-2H-chromen-4-yl]amino}imidazo[1,2-a]pyridine-6-carboxamide (PF-03716556), a Novel, Potent, and Selective Acid Pump Antagonist for the Treatment of Gastroesophageal Reflux Disease

N. Takahashi, Hiroyuki Ohshiro, M. Sakakibara, 2009, Journal of Pharmacology and Experimental Therapeutics.